These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 18423620)

  • 1. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
    Jones JL; Glynn P; Walker RA
    J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma.
    El-Shabrawi Y; Ardjomand N; Radner H; Ardjomand N
    J Pathol; 2001 Jun; 194(2):201-6. PubMed ID: 11400149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
    Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
    J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
    Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
    Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer.
    Thomas P; Khokha R; Shepherd FA; Feld R; Tsao MS
    J Pathol; 2000 Feb; 190(2):150-6. PubMed ID: 10657012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y; Koda M; Murawaki Y
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities.
    Roebuck MM; Helliwell TR; Chaudhry IH; Kalogrianitis S; Carter S; Kemp GJ; Ritchie DA; Jane MJ; Frostick SP
    Am J Clin Pathol; 2005 Mar; 123(3):405-14. PubMed ID: 15716237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin.
    Massi D; Franchi A; Ketabchi S; Paglierani M; Pimpinelli N; Santucci M
    Hum Pathol; 2003 Jan; 34(1):80-8. PubMed ID: 12605370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.
    Steen B; Sejersen S; Berglin L; Seregard S; Kvanta A
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2194-200. PubMed ID: 9761302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
    Curran S; Dundas SR; Buxton J; Leeman MF; Ramsay R; Murray GI
    Clin Cancer Res; 2004 Dec; 10(24):8229-34. PubMed ID: 15623598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
    Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinase, collagens, and Ki67 antigen in pleural malignant mesothelioma: an immunohistochemical and electron microscopic study.
    Hirano H; Tsuji M; Kizaki T; Sashikata T; Yoshi Y; Okada Y; Mori H
    Med Electron Microsc; 2002 Mar; 35(1):16-23. PubMed ID: 12111403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
    Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
    Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
    Goffin F; Munaut C; Frankenne F; Perrier D'Hauterive S; Béliard A; Fridman V; Nervo P; Colige A; Foidart JM
    Biol Reprod; 2003 Sep; 69(3):976-84. PubMed ID: 12773401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm].
    Wan Y; Wei Q; Pan Y; Liu Y
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):510-3. PubMed ID: 11832095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues.
    Ogasawara S; Yano H; Momosaki S; Nishida N; Takemoto Y; Kojiro S; Kojiro M
    Oncol Rep; 2005 Jun; 13(6):1043-8. PubMed ID: 15870919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
    Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
    Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
    J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.